בינוקריט 3000 יחבל  0.3 מל ישראל - עברית - Ministry of Health

בינוקריט 3000 יחבל 0.3 מל

novartis israel ltd - epoetin alfa - תמיסה להזרקה - epoetin alfa 3000 iu / 0.3 ml - erythropoietin - erythropoietin - treatment of symptomatic anaemia associated with chronic renal failure (crf) in adult and paediatric patients:- treatment of anaemia associated with chronic renal failure in paediatric and adult patients on haemodialysis and adult patients on peritoneal dialysis.- treatment of severe anaemia of renal origin accompanied by clinical symptoms in adult patients with renal insufficiency not yet undergoing dialysis. treatment of anaemia and reduction of transfusion requirements in adult patients receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma, and at risk of transfusion as assessed by the patient's general status (e.g. cardiovascular status, pre existing anaemia at the start of chemotherapy). binocrit can be used to increase the yield of autologous blood from patients in a predonation programme. its use in this indication must be balanced against the reported risk of thromboembolic events. treatment should only be given to non-iron deficient patients with moderate anaemia (haemoglob

בינוקריט 40000 יחבל  1 מל ישראל - עברית - Ministry of Health

בינוקריט 40000 יחבל 1 מל

novartis israel ltd - epoetin alfa - תמיסה להזרקה - epoetin alfa 40000 iu / 1 ml - erythropoietin - erythropoietin - treatment of symptomatic anaemia associated with chronic renal failure (crf) in adult and paediatric patients:- treatment of anaemia associated with chronic renal failure in paediatric and adult patients on haemodialysis and adult patients on peritoneal dialysis.- treatment of severe anaemia of renal origin accompanied by clinical symptoms in adult patients with renal insufficiency not yet undergoing dialysis. treatment of anaemia and reduction of transfusion requirements in adult patients receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma, and at risk of transfusion as assessed by the patient's general status (e.g. cardiovascular status, pre existing anaemia at the start of chemotherapy). binocrit can be used to increase the yield of autologous blood from patients in a predonation programme. its use in this indication must be balanced against the reported risk of thromboembolic events. treatment should only be given to non-iron deficient patients with moderate anaemia (haemoglob

Discovery NM 530c (Ventri 1.1) ישראל - עברית - Ministry of Health

discovery nm 530c (ventri 1.1)

ג'י אי מדיקל סיסטמס ישראל - צוות טכני - system is to perform nuclear imaging procedures for detection and imaging of radioisotope tracer uptake in the patient body for clinical diagnostic purposes. discovery nm 530c is primarily intended for cardiac applications.

Discovery NM/CT 570c ישראל - עברית - Ministry of Health

discovery nm/ct 570c

ג'י אי מדיקל סיסטמס ישראל - צוות טכני - the discovery nm/ct 570c system intended uses include performing nuclear cardiac imaging procedures for detection and imaging of radioisotope tracer uptake in the patient body for clinical diagnostic purposes as well as performing general head & body computed tomography (ct) applications

Abbott FreeGo Enteral Feeding Pump ישראל - עברית - Ministry of Health

abbott freego enteral feeding pump

אבוט מעבדות רפואיות בע"מ באמצעות פרומדיקו בע"מ - אחות - enteral tube feeding is a method of providing nutrition to patients whose nutrition needs cannot be met by oral intake alone, for variety of clinical reasons. enteral feeding may be indicated for patients: who have difficulty chewing or swallowing, e.g. sroke, post-operative patients; with loss appetite due to chronic illness, e.g. cancer, hiv; with increased nutritional needs, e.g. wound healing, trauma/injury; with gastrointestinal disease, e.g. cancers of gi tract.